Media - Immunity Pharma

ALS News Today: Investigational Treatment IPL344 Safely Slows ALS Progression in Small Phase 1/2a Trial

9 December 2023

Read More

Neurology Live: Akt Activator IPL344 Demonstrates Safety, Signs of Efficacy in Phase 1/2 Study of ALS

4 November 2022

Read More

ALS News Today: IPL344

8 December 2020

Read More

© 2025 Immunity Pharma Ltd.